Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 8, 2000, Pages 1939-1945

  Thorngate, Fayanne E ^a   Rudel, Lawrence L ^b   Walzem, Rosemary L ^c   Williams, David L ^a,d  

^a STONY BROOK UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ApoE; Atherosclerosis; Hypercholesterolemia; Transgenic apoE knockout mice

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN;

ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033877143     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.8.1939     Document Type: Article

References (51)

1. Cardiovascular disease burden increases, NIH funding decreases
2. Atherosclerosis: An inflammatory disease
3. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
4. Familial apolipoprotein E deficiency
5. Type III hyperlipoproteinemia
6. Atherosclerosis in mice lacking apo E: Evaluation of lesional development and progression
7. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
8. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
9. Peripheral vascular stenosis in apolipoprotein E-deficient mice: Potential roles of lipid deposition, medial atrophy, and adventitial inflammation
10. Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
11. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall
12. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice
13. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
14. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
15. Bone marrow transplantation in apolipoprotein E-deficient mice: Effect of apoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis
16. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice
17. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
18. Apolipoprotein E synthesis in human kidney, adrenal gland, and liver
19. Apolipoprotein E synthesis in peripheral tissues of nonhuman primates
20. Quantification and regulation of apolipoprotein E expression in rat Kupffer cells
21. Variegated expression of a mouse steroid 21-hydroxlase/b-galactosidase transgene suggests centripetal migration of adrenocortical cells
22. A non-curved chicken lysozyme 5' matrix attachment site is 3' followed by a strongly curved DNA sequence
23. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice
24. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
25. Protein measurement with the folin phenol reagent
26. A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic
27. Peritoneal mononuclear phagocytes from small animals
28. Reactivation of apolipoprotein II gene transcription by cycloheximide reveals two steps in the deactivation of estrogen receptor-mediated transcription
29. Differential regulation of apolipoprotein-E messenger RNA in zona fasciculata cells of rat adrenal gland determined by in situ hybridization
30. A competitive reverse transcription-PCR to study apolipoprotein epsilon gene expression
31. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
32. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition
33. A minimally-lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins
34. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100-overexpressing transgenic mice
35. An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene
36. Relationship between apolipoprotein E mRNA expression and tissue cholesterol content in rat adrenal gland
37. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice
38. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
39. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient Mice
40. Lipoprotein clearance mechanisms in LDL receptor-deficient 'apo-B48-only' and 'apo-B100-only' mice
41. Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance
42. The response-to-retention hypothesis of early atherogenesis
43. Ultrastructure of early lipid accumulation in apoE-deficient mice
44. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse
45. Chemokines and atherosclerosis
46. Suppression of cAMP-mediated signal transduction in mouse adrenocortical cells which express apolipoprotein E
47. Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis
48. Apolipoprotein E inhibits platelet aggregation through the L-arginine: Nitric oxide pathway. Implications for vascular disease
49. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In
50. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins